Results
11
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
11 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
BSX * | US$1,563.67 | -3.9% | 71.1% | US$122.7b | US$1,637.05 | PE67.1x | E20.9% | n/a | ||
DXCM * | US$1,340.00 | 0% | n/a | US$27.0b | US$1,914.19 | PE40.4x | E16.5% | n/a | ||
STE N | US$3,824.43 | 0% | -19.4% | US$22.1b | US$4,127.51 | PE185.6x | E32.3% | 0.9% | ||
STMN N | CHF 2,577.02 | 0% | n/a | CHF 19.1b | CHF 2,878.87 | PE77.8x | E20.9% | 0.7% | ||
GMED * | US$1,341.00 | 0% | n/a | US$9.6b | US$1,506.18 | PE235.1x | E53.3% | n/a | ||
PEN * | US$3,516.00 | 0% | -28.3% | US$7.9b | US$3,393.69 | PE556x | E44.2% | n/a | ||
AMBU N | DKK 697.47 | 0% | 0% | DKK 28.2b | DKK 675.42 | PS6.1x | E48.1% | 0% | ||
CERT * | US$359.40 | 0% | n/a | US$3.9b | US$367.09 | PE261.7x | E38.0% | n/a | ||
HIMS * | US$341.00 | 7.2% | n/a | US$3.8b | US$420.80 | PE212.5x | E40.7% | n/a | ||
AXNX * | US$1,227.00 | 0% | n/a | US$3.6b | US$1,263.22 | PS8.7x | E50.4% | n/a | ||
4483 N | JP¥1,001.68 | 0% | 0% | JP¥368.2b | JP¥1,146.13 | PE87.7x | E22.7% | 0.2% |